Wednesday, April 09, 2014 8:38:20 AM
Cardiff International, Inc.'s (OTCQB:CDIF) CEO Daniel Thompson announced today Cardiff (CDIF) is near completing its restructuring as a Holding Company.Cardiff's new business model (www.cardiffusa.com) is specializing in the acquisition of undervalued, emerging niche companies with good management that are stable, revenue producing, real estate, equities, and other proven assets that meet our minimum requirements. Mission Tuition will remain within Cardiff as a wholly-owned subsidiary with new management at the helm.Thompson stated, "We have worked hard the last 16 months restructuring Cardiff, getting current with our filings, reducing debt, and finding the appropriate management team to move forward.I believe Cardiff has made the right changes to become a successful consortium in this ever changing economy."
Management will seek to have a more transparent dialogue with its current and future investors as to the clarity of the Company's goals and objectives. Our goal is to create a higher standard for shareholder value by both increasing bottom line revenue and decreasing overall costs.
FORWARD-LOOKING STATEMENT
CDIF cautions that the statements made in this press release constitute forward-looking statements, and not guarantees of future performance, and that actual results or developments may differ materially from the projections in the forward-looking statements. Forward-looking statements are based on the estimates and opinions of management at the time the statements are made.
Contact: Cardiff International, Inc. investorrelations@cardiffusa.com
SOURCE: Cardiff International, Inc.
Recent CDIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:50:17 PM
- Form DEFR14C - Revised information statement materials, definitive • Edgar (US Regulatory) • 11/29/2023 03:18:50 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 11/16/2023 09:11:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 07:06:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:29:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/25/2023 07:05:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 07:56:42 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 05:25:09 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/03/2023 08:51:51 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/19/2023 09:02:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/29/2023 08:04:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM